IL-17 Producing T cells as Predictors of Primary Immunodeficiencies in Patients with Candida Infections
Open Access
- 19 May 2022
- journal article
- research article
- Published by Brieflands in Archives of Pediatric Infectious Diseases
- Vol. 10 (3)
Abstract
Background: IL-17 producing T cells are a distinct subset of CD4+ T cells, which are recognized to have an essential role in protection against certain fungi and extracellular pathogens. Objectives: This study aims to evaluate the number of IL-17 producing T cells as a predictor of primary immunodeficiency disorders in patients with Candida infections and low numbers of IL-17 producing T cells. Methods: Seven newly diagnosed patients with documented Candida infections aged between 4 and 35 years were included in this study. Before establishing the diagnosis of chronic mucocutaneous candidiasis, a thorough immunodeficiency workup, including complete blood count, serum Ig levels and antibody responses, flow-cytometry evaluation, and LTT, was completed for all the patients, and other immunodeficiency disorders, including combined and phagocytic deficiencies, were ruled out. Then, IL-17 producing T cells were detected using antiCD3 and anti-IL-17 antibodies through flow-cytometry evaluation. Results: The IL-17 producing T cells significantly decreased in the peripheral blood of patients with PID and candida infections. A P-value of less than 0.05 was considered statistically significant. Conclusions: To conclude, in cases of recurrent candida infections, initial assessment of IL-17 producing T cells may act as a predictor of an underlying primary immunodeficiency. In patients with low counts of IL-17 producing T cells, selecting a targeted panel of genetic tests may become more helpful in the detection of certain immunodeficiency disorders than performing whole-exome sequence analysis.Keywords
This publication has 16 references indexed in Scilit:
- Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infectionsMucosal Immunology, 2012
- Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1βNature, 2012
- TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?Frontiers in Immunology, 2012
- Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapyArthritis Research & Therapy, 2012
- Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 ImmunityScience, 2011
- A HomozygousCARD9Mutation in a Family with Susceptibility to Fungal InfectionsNew England Journal of Medicine, 2009
- TH17 cells and regulatory T cells in primary immunodeficiency diseasesJournal of Allergy and Clinical Immunology, 2009
- Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 Journal of Experimental Medicine, 2008
- Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineagesNature Immunology, 2005
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003